FRLN
Price:
$6.49
Market Cap:
$28.28M
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in Phase 1/2 clinical trials in adult males for the treatment of hemophilia B. The company's products also include FLT190, which is in Phase 1/2 clinical trial for the treatment of Fabry disease; and FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease and is under Phase 1/2 clinical trial. In addition, it has research p...[Read more]
Industry
Biotechnology
IPO Date
2020-08-07
Stock Exchange
NASDAQ
Ticker
FRLN
According to Freeline Therapeutics Holdings plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.57. This represents a change of -141.70% compared to the average of 1.37 of the last 4 quarters.
The mean historical PE Ratio of Freeline Therapeutics Holdings plc over the last ten years is -1.81. The current -0.57 PE Ratio has changed 3.04% with respect to the historical average. Over the past ten years (40 quarters), FRLN's PE Ratio was at its highest in in the March 2023 quarter at 6.36. The PE Ratio was at its lowest in in the March 2018 quarter at -173.21.
Average
-1.81
Median
-2.12
Minimum
-3.43
Maximum
-0.32
Discovering the peaks and valleys of Freeline Therapeutics Holdings plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 26.59%
Maximum Annual PE Ratio = -0.32
Minimum Annual Increase = -81.23%
Minimum Annual PE Ratio = -3.43
Year | PE Ratio | Change |
---|---|---|
2022 | -0.32 | -37.12% |
2021 | -0.50 | -81.23% |
2020 | -2.68 | 26.59% |
2019 | -2.12 | -38.26% |
The current PE Ratio of Freeline Therapeutics Holdings plc (FRLN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.17
5-year avg
-1.81
10-year avg
-1.81
Freeline Therapeutics Holdings plc’s PE Ratio is less than CNS Pharmaceuticals, Inc. (-0.00), less than ZyVersa Therapeutics, Inc. (-0.10), less than eFFECTOR Therapeutics, Inc. (-0.00), greater than VectivBio Holding AG (-7.94), less than AVROBIO, Inc. (2.07), greater than Immix Biopharma, Inc. (-2.98), less than Hepion Pharmaceuticals, Inc. (-0.15), less than Navidea Biopharmaceuticals, Inc. (0.03), less than Sonnet BioTherapeutics Holdings, Inc. (-0.55),
Company | PE Ratio | Market cap |
---|---|---|
-0.00 | $4.60M | |
-0.10 | $2.70M | |
-0.00 | $188.18K | |
-7.94 | $1.06B | |
2.07 | $5.24M | |
-2.98 | $54.08M | |
-0.15 | $4.20M | |
0.03 | $100.08K | |
-0.55 | $4.53M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Freeline Therapeutics Holdings plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Freeline Therapeutics Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Freeline Therapeutics Holdings plc's PE Ratio?
How is the PE Ratio calculated for Freeline Therapeutics Holdings plc (FRLN)?
What is the highest PE Ratio for Freeline Therapeutics Holdings plc (FRLN)?
What is the 3-year average PE Ratio for Freeline Therapeutics Holdings plc (FRLN)?
What is the 5-year average PE Ratio for Freeline Therapeutics Holdings plc (FRLN)?
How does the current PE Ratio for Freeline Therapeutics Holdings plc (FRLN) compare to its historical average?